of time and at a higher rate than other currencies in competing markets, especially China. Despite the increase in raw material price and the baht’s strengthening, the Company was capable to maintain a
expenses This Year the Company had the selling and administrative expenses of 366.19 Million Baht, increase by 113.99 Million Baht or up by 45.20% from the previous year. Due to, the cost of sales increased
last year. Caused by the sale of long outstanding products. The company must bring the product (Rework) to get the product ready to sell. 3. The increase in selling and administrative expenses was 37.65
increase 0.9 percent and Export sales decrease 4.0 percent) Gross profit margin In the year 2019, the Company and its subsidiaries had the total gross profit of 315.6 MB decreased from the year 2018 in the
138.3 million baht, which was an increase from the 3rd quarter of 2017 at 40.0 percent. The Company’s net profit margin stood at 28.7 percent. An increase of net profit was a result of the Company has
security revenue , the Company posted 20% growth in 3Q17 which was attributable to the increase of number of patients and bill amount. Cost of Hospital Operations Cost of hospital operations during 9M17
573.76% the company has revenue from export. 3. Other income in the amount of 5.56 million baht, compared to the year 2018, amounting to 2.84 million baht, an increase of 3.47 million baht or 166.60% due
(Thailand) Public Company Limited (“INGRS”or “the Company”) would like to provide an explanation about our 3-months financial performance for the period ended 30 April 2019: 1. Sales Revenue For the 3-months
statements for third quarter of year 2018 ended September 30,2018. The details are as follows: 1. For the 3rd quarter of year 2018, total revenue from sales was 476.4 million Baht, or an increase of 46.72
capital increase proposal for private placement, feasibility and objective for company?s interest including appropriateness of placement method, placement price and price determination as well as share